Vision & Team
Resources For Immunologists
Federations and Societies
Education & Careers
IUIS Webinar: COVID-19 Monoclonal Abs
Aging & COVID-19
Immuno-Ethiopia: Sand flies & Leishmaniasis
Innate T cells & severe COVID-19
Multi-organ damage is a hallmark of severe COVID-19
IUIS Webinar: COVID-19 in South Africa
Are polymorphisms in the ACE2 locus important for COVID-19 severity?
Immuno-Ethiopia: Genetics of Fungal Immunology
Do mutations in the SARS-CoV-2 spike protein enhances viral infectivity?
Will the COVID-19 pandemic result in significant neuropsychiatric sequelae?
IUIS Webinar: Involvement of C5a-C5aR1 axis in COVID-19 pathology
How effective is Dexamethasone for the treatment of patients with COVID-19?
SARS-CoV-2-specific IgG and IgM in asymptomatic individuals wane quickly
Does breast milk contain SARS-CoV-2?
Are blood groups associated with severe COVID-19 respiratory failure?
Development of an inactivated vaccine candidate for SARS-CoV-2
IUIS Webinar: Understanding Infection and Immunity of SARS-CoV-2
IUIS Webinar: Respiratory Immunity and COVID-19
Identification of two B cell epitopes that induce neutralising Ab in COVID-19 patients
COVID-19 vaccines: can alum based adjuvants improve induction of nAbs?
What evidence is there for pre-existing antibody responses to SARS-CoV-2?
Is COVID-19 an endothelial disease?
A recombinant adenovirus type-5 vectored COVID-19 vaccine appears safe and immunogenic in a first-in-human trial
SARS-CoV-2 monkey model shows protection from re-infection
An exuberant inflammatory host response to SARS-CoV-2 leads to COVID-19
IUIS Webinar: Role of cellular responses in COVID-19
SARS-CoV-2 infection in young children and Kawasaki-like disease
No evidence that BCG vaccination can protect against SARS-CoV-2 infection
Do we have more T cell immunity to SARS-CoV-2 than we think?
Is the rapid generation of neutralizing antibodies to SARS-CoV-2 good news for preventing reinfection?
The current status of COVID-19 immunology
IUIS Webinar: Trained immunity and BCG vaccination: a tool against COVID-19?
A nail in the coffin of (hydro)chloroquine treatment against COVID-19?
SARS-CoV-2 found in semen
Can anti-HIV drugs, Lopinavir and Ritonavir, be used to treat patients with severe COVID-19?
Can the Cytokine Release Syndrome in COVID-19 patients be treated using CCR5 blocking antibody therapy?
IUIS Webinar: Adaptive Immunity in COVID-19
Can a Chimpanzee vector vaccine prevent SARS-CoV-2 pneumonia?
Getting to the guts of SARS-CoV-2 infection
Cigarette smoke triggers increased ACE-2 expression in the lung
Respiratory disease and viral shedding in rhesus macaques inoculated with SARS-CoV-2
IUIS Webinar: What cancer immunologists are doing about COVID-19?
BCG induced trained immunity & COVID-19
Is there a SARS-CoV-2 receptor (ACE2) expression difference between males and females?
Roles of different anti-SARS-CoV-2 antibodies in COVID-19 disease and protection
Opinion: Exaggerated immune response to COVID-19
Can neonates born to mothers with COVID-19 acquire maternal infection?
Mutation in the Spike protein may explain higher infectivity of SARS-CoV-2 and accelerated disease
IUIS Webinar: Global outbreaks – Interferons as 1st responders
An inventory of the vaccine candidates to SARS-CoV-2
COVID-19: extending or relaxing distancing control measures
Is a self-amplifying RNA SARS-CoV-2 lipid nanoparticle a good vaccine candidate?
SARS-CoV-2 transmission exploits existing secretory pathways in the nasal cavity: a vaccine/drug target?
The role of complement in COVID-19 pathogenesis
Scientific Response to COVID-19 Video
Can two FDA-approved drugs be re-purposed to clear SARS-CoV-2 infection?
Should we consider SARS-CoV-2 human challenge models for vaccine testing?
Mask wearing to reduce the spread of COVID-19
Development of inactivated SARS-CoV-2 vaccines
Cytokine Release Syndrome & COVID-19
COVID-19 Antibody Immunology Video
Uncertainty is hampering doctors’ ability to treat COVID-19
Detection of SARS-CoV-2 nAbs in cats
Susceptibility of domestic animals to SARS-Cov-2
Opinion: Indian population could have intrinsic immunity to resist COVID-19 challenge
Viral dynamics in mild vs severe COVID-19
SARS-CoV-2 transmission and mask wearing
Convalescent sera option for containing COVID-19
Webinar: Rino Rappuoli on COVID-19 Vaccines – 6th April
COVID-19 and SARS-CoV-2
FAIS Legacy Report – Selassie Kumordjie
FAIS Legacy Project – Esemu Livo Forgu Report
FAIS at the 17th International Congress of Immunology
FAIS President and Secretary General in Innovations in Immunology
FAIS in Beijing
FAIS Legacy Project – Student Feedback
The Mawazo Institute’s PhD Scholars Programme
FAIS President Honoured
The FAIS Legacy Project in Nature